Hong-Jae Chon

39PUBLICATIONS
209CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Computational linguisticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Sep 26, 2026
Prognostic Role of Adverse Events in a Worldwide Population of Patients with Biliary Tract Cancer Treated with Chemo-Immunotherapy.

|Sep 17, 2026
Large Language Models in Multidisciplinary Decision-Making for Hepatopancreatobiliary Oncology: Retrospective Comparative Feasibility Study.

|Jun 09, 2026
A Phase Ib/IIa Study of Fostrox in Combination with Lenvatinib as Second-line Therapy in Patients with Advanced Hepatocellular Carcinoma.

|Feb 02, 2026
Prognostic Value of FDG PET/CT Parameters in Patients With Advanced Biliary Tract Cancer Receiving Gemcitabine, Cisplatin, and Nab-Paclitaxel.

Jeong Won Lee, Sang Mi Lee, Beodeul Kang

|Dec 26, 2025
Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study.

Jung Sun Kim, Jeffrey Wong, San-Chi Chen

|Dec 18, 2025
Elevated antidrug antibodies against atezolizumab and associated clinical outcomes in advanced non-small-cell lung cancer.

Miran Jang, Chan Kim, So Jung Kong

Pageof 7

Frequent Collaborators

14 joint publications

Chan Kim

5 joint publications

Jung Sun Kim

5 joint publications

Beodeul Kang

4 joint publications

Jaekyung Cheon